Charles Schwab’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $369M | Sell |
1,554,017
-7,137
| -0.5% | -$1.48M | 0.05% | 298 |
|
|
2026
Q1 | $330M | Buy |
1,561,154
+3,564
| +0.2% | +$768K | 0.05% | 291 |
|
|
2025
Q4 | $320M | Buy |
1,557,590
+5,243
| +0.3% | +$987K | 0.05% | 298 |
|
|
2025
Q3 | $244M | Buy |
1,552,347
+30,222
| +2% | +$4.67M | 0.04% | 356 |
|
|
2025
Q2 | $256M | Buy |
1,522,125
+1,761
| +0.1% | +$261K | 0.04% | 337 |
|
|
2025
Q1 | $209M | Buy |
1,520,364
+1,353
| +0.1% | +$172K | 0.04% | 369 |
|
|
2024
Q4 | $180M | Buy |
1,519,011
+44,386
| +3% | +$5.18M | 0.03% | 418 |
|
|
2024
Q3 | $163M | Buy |
1,474,625
+33,388
| +2% | +$3.49M | 0.03% | 439 |
|
|
2024
Q2 | $142M | Sell |
1,441,237
-2,327
| -0.2% | -$237K | 0.03% | 491 |
|
|
2024
Q1 | $162M | Sell |
1,443,564
-9,342
| -0.6% | -$1.01M | 0.04% | 414 |
|
|
2023
Q4 | $146M | Sell |
1,452,906
-61,638
| -4% | -$6.12M | 0.04% | 413 |
|
|
2023
Q3 | $131M | Sell |
1,514,544
-37,212
| -2% | -$3.36M | 0.04% | 405 |
|
|
2023
Q2 | $147M | Sell |
1,551,756
-47,893
| -3% | -$4.05M | 0.04% | 382 |
|
|
2023
Q1 | $121M | Sell |
1,599,649
-86,419
| -5% | -$6.52M | 0.04% | 431 |
|
|
2022
Q4 | $130M | Sell |
1,686,068
-133,034
| -7% | -$10.1M | 0.04% | 395 |
|
|
2022
Q3 | $121M | Sell |
1,819,102
-38,052
| -2% | -$2.41M | 0.04% | 375 |
|
|
2022
Q2 | $97.1M | Sell |
1,857,154
-80,314
| -4% | -$4.56M | 0.03% | 464 |
|
|
2022
Q1 | $110M | Buy |
1,937,468
+41,859
| +2% | +$2.24M | 0.03% | 479 |
|
|
2021
Q4 | $97.6M | Buy |
1,895,609
+88,429
| +5% | +$4.34M | 0.03% | 538 |
|
|
2021
Q3 | $89.4M | Buy |
1,807,180
+45,137
| +3% | +$2.45M | 0.03% | 545 |
|
|
2021
Q2 | $101M | Buy |
1,762,043
+35,234
| +2% | +$2.06M | 0.03% | 490 |
|
|
2021
Q1 | $105M | Sell |
1,726,809
-99,136
| -5% | -$5.47M | 0.04% | 432 |
|
|
2020
Q4 | $97.8M | Sell |
1,825,945
-5,297
| -0.3% | -$275K | 0.04% | 425 |
|
|
2020
Q3 | $86M | Sell |
1,831,242
-254,191
| -12% | -$13M | 0.04% | 401 |
|
|
2020
Q2 | $109M | Sell |
2,085,433
-1,118,587
| -35% | -$57.7M | 0.05% | 321 |
|
|
2020
Q1 | $154M | Buy |
3,204,020
+249,595
| +8% | +$13M | 0.09% | 219 |
|
|
2019
Q4 | $149M | Sell |
2,954,425
-107,752
| -4% | -$5.57M | 0.08% | 228 |
|
|
2019
Q3 | $145M | Buy |
3,062,177
+256,016
| +9% | +$11.7M | 0.09% | 221 |
|
|
2019
Q2 | $132M | Buy |
2,806,161
+133,972
| +5% | +$6.18M | 0.08% | 243 |
|
|
2019
Q1 | $129M | Buy |
2,672,189
+161,921
| +6% | +$8.11M | 0.08% | 229 |
|
|
2018
Q4 | $112M | Buy |
2,510,268
+107,578
| +4% | +$5.61M | 0.09% | 211 |
|
|
2018
Q3 | $130M | Buy |
2,402,690
+99,720
| +4% | +$5.1M | 0.09% | 209 |
|
|
2018
Q2 | $112M | Buy |
2,302,970
+96,947
| +4% | +$5.5M | 0.08% | 228 |
|
|
2018
Q1 | $138M | Buy |
2,206,023
+853,062
| +63% | +$58.5M | 0.11% | 180 |
|
|
2017
Q4 | $82.9M | Buy |
1,352,961
+72,892
| +6% | +$4.51M | 0.07% | 281 |
|
|
2017
Q3 | $85.7M | Buy |
1,280,069
+63,151
| +5% | +$4.46M | 0.07% | 251 |
|
|
2017
Q2 | $94.8M | Buy |
1,216,918
+56,974
| +5% | +$4.3M | 0.09% | 220 |
|
|
2017
Q1 | $94.6M | Buy |
1,159,944
+15,308
| +1% | +$1.2M | 0.09% | 204 |
|
|
2016
Q4 | $82.4M | Sell |
1,144,636
-461,691
| -29% | -$33.4M | 0.09% | 213 |
|
|
2016
Q3 | $124M | Sell |
1,606,327
-14,986
| -0.9% | -$1.21M | 0.15% | 135 |
|
|
2016
Q2 | $127M | Buy |
1,621,313
+32,197
| +2% | +$2.57M | 0.16% | 121 |
|
|
2016
Q1 | $130M | Sell |
1,589,116
-91,228
| -5% | -$7.42M | 0.17% | 109 |
|
|
2015
Q4 | $150M | Sell |
1,680,344
-274,923
| -14% | -$23.3M | 0.2% | 92 |
|
|
2015
Q3 | $151M | Sell |
1,955,267
-495,015
| -20% | -$41.4M | 0.22% | 85 |
|
|
2015
Q2 | $205M | Buy |
2,450,282
+97,085
| +4% | +$8.57M | 0.28% | 69 |
|
|
2015
Q1 | $212M | Buy |
2,353,197
+13,217
| +0.6% | +$1.14M | 0.3% | 60 |
|
|
2014
Q4 | $189M | Sell |
2,339,980
-153,342
| -6% | -$12.1M | 0.28% | 64 |
|
|
2014
Q3 | $187M | Sell |
2,493,322
-36,224
| -1% | -$2.64M | 0.31% | 58 |
|
|
2014
Q2 | $173M | Buy |
2,529,546
+900,773
| +55% | +$61.3M | 0.29% | 62 |
|
|
2014
Q1 | $114M | Buy |
1,628,773
+646,950
| +66% | +$45M | 0.2% | 95 |
|
|
2013
Q4 | $65.6M | Buy |
981,823
+165,399
| +20% | +$10.1M | 0.12% | 162 |
|
|
2013
Q3 | $43.3M | Buy |
816,424
+3,311
| +0.4% | +$168K | 0.09% | 228 |
|
|
2013
Q2 | $38.7M | Buy |
+813,113
| New | +$37.1M | 0.09% | 223 |
|
Other funds holding CAH
Charles Schwab's CAH Position: Q2 2026 in Review
Charles Schwab reduced its Cardinal Health (CAH) stake by 0.46% in Q2 2026, selling an estimated $1.48M and leaving 1,554,017 shares worth $369M. The position accounts for 0.05% of the portfolio, ranked #298.
Charles Schwab first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Charles Schwab held 1,554,017 shares of Cardinal Health worth $369M as of Q2 2026.
- Charles Schwab sold 7,137 Cardinal Health shares in Q2 2026, an estimated $1.48M.
- Cardinal Health made up 0.05% of Charles Schwab's portfolio in Q2 2026, its #298 holding.
- Charles Schwab first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
- 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.